06:10a | Bayer aims to help CureVac with COVID-19 vaccine output, says CEO | RE |
03:55a | Swiss to get Moderna vaccine in tranches until mid-year - Blick | RE |
01/16 | Samsung's Jay Y. Lee on cusp of stepping out of father's shadow | RE |
01/15 | PFIZER : Biden to Outline Plans for Bigger Federal Role in Covid-19 Vaccinations.. | DJ |
01/15 | PFIZER : Vaccine Shortfall to Hit Europe, Canada as Pfizer Plant Is Upgraded | DJ |
01/15 | New hedge fund Honest Capital gains 88% with bets on cannabis, others | RE |
01/15 | MODERNA : WHO sees poorer countries getting first COVID vaccines this quarter | RE |
01/15 | Bans on GMO corn, glyphosate in Mexico would shrink food supplies, industry s.. | RE |
01/15 | SANOFI : Deutsche Bank Initiates Coverage on Sanofi With Sell Rating | MT |
01/15 | SINOVAC BIOTECH : Brazil airlifts emergency oxygen into pandemic-struck state, v.. | RE |
01/15 | NOVARTIS : Deutsche Bank Starts Novartis at Buy | MT |
01/15 | ASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating | MT |
01/15 | GLAXOSMITHKLINE : Deutsche Bank Starts GlaxoSmithKline at Hold | MT |
01/15 | NOVO NORDISK A/S : Deutsche Bank Initiates Coverage on Novo Nordisk A/S With Buy.. | MT |
01/15 | BRISTOL MYERS SQUIBB : UBS Adjusts Price Target on Bristol-Myers Squibb to $66 F.. | MT |
01/15 | PRESS RELEASE : BP p.l.c.: BP announces non-executive director resignation | DJ |
01/15 | ELI LILLY AND : Lilly Invests $30 Million in Venture Fund for Underrepresented F.. | DJ |
01/15 | NOVO NORDISK : Buy rating by Deutsche Bank | MD |
01/15 | SANOFI : Gets a Sell rating from Deutsche Bank | MD |
01/15 | ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating | MD |
01/15 | GLAXOSMITHKLINE : Deutsche Bank gives a Neutral rating | MD |
01/15 | NOVARTIS AG : Gets a Buy rating from Deutsche Bank | MD |
01/15 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
01/15 | NOVARTIS : Exane BNP Paribas Lowers Price Target on Novartis, Maintains Outperfo.. | MT |
01/15 | GLAXOSMITHKLINE : JP Morgan gives a Neutral rating | MD |
01/15 | ASTRAZENECA : Buy rating from Berenberg | MD |
01/14 | EXCLUSIVE : India to treat homegrown COVID-19 vaccine same as AstraZeneca's | RE |
01/14 | MODERNA : U.S. big-city mayors ask Biden for direct shipments of COVID-19 vaccin.. | RE |
01/14 | PFIZER : Israel Vaccine Data Suggests Decrease in Covid-19 Infection Rate After .. | DJ |
01/14 | UK to step up coronavirus vaccinations -FT | RE |
01/14 | Qiagen warns against using standard tests to track coronavirus variants | RE |
01/14 | Microsoft, Cigna form coalition for digital records of COVID-19 vaccination | RE |
01/14 | WRAPUP 1-China steals march on West in developing nations' vaccine rollout | RE |
01/14 | Aphria posts quarterly profit on cannabis demand, shares jump | RE |
01/14 | Correction to South Africa Skips National Regulatory Approval to Secure Covid.. | DJ |
01/14 | BAYER AG : NorldLB reaffirms its Buy rating | MD |
01/14 | ASTRAZENECA : UBS reaffirms its Neutral rating | MD |
01/14 | Serum Institute expects WHO emergency approval for AstraZeneca shot soon | RE |
01/14 | NOVARTIS : Gets FDA Breakthrough-Therapy Designation for Ligelizumab | DJ |
01/14 | SANOFI : JP Morgan reiterates its Buy rating | MD |
01/14 | Unilever gets vaccine partnership offers as it plots worker safety strategy | RE |
01/14 | NOVARTIS AG : UBS maintains a Buy rating | MD |
01/14 | ASTRAZENECA : Serum Institute expects WHO emergency approval for AstraZeneca sho.. | RE |
01/14 | DGAP-PVR : Merck KGaA: Release according to -3- | DJ |
01/14 | DGAP-PVR : Merck KGaA: Release according to -4- | DJ |
01/14 | DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t.. | DJ |
01/14 | DGAP-PVR : Merck KGaA: Release according to -2- | DJ |
01/14 | Philippines approves Pfizer-BioNTech vaccine for emergency use | RE |
01/13 | JOHNSON & JOHNSON : Favorable Data Published About Johnson & Johnson Covid-19 Va.. | DJ |
01/13 | Federal Vaccine Distribution Changes Draw Concern at Local Level | DJ |